NCT02462395View on ClinicalTrials.gov

Anodal Transcranial Direct Stimulation (tDCS) for the Treatment of Chronic Cluster Headache

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Chronic Cluster Headache
Interventions
DEVICE

tDCS

"Sponge-electrodes (5 x 7 cm) will be postioned at Fz (anode) and over the spinous process of C7 (cathode). Stimulation intensity will be set to 2 mA.~A first group of CCH patients will have to apply the neurostimulation outside of an attack every day for 20 minutes during 4 weeks. A second group will use the tDCS device everyday for 8 weeks.~Adherence to the treatment will be evaluated by monitoring the time during which the device is switched on via an in-built software."

Trial Locations (1)

4000

CHR Citadelle, Liège

All Listed Sponsors
lead

University of Liege

OTHER

NCT02462395 - Anodal Transcranial Direct Stimulation (tDCS) for the Treatment of Chronic Cluster Headache | Biotech Hunter | Biotech Hunter